Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients: A Randomized, Open-label, Multicenter Clinical Trial
Phase of Trial: Phase IV
Latest Information Update: 01 Nov 2019
Price : $35 *
At a glance
- Drugs Tacrolimus (Primary) ; Tacrolimus (Primary) ; Corticosteroids; Mycophenolic acid
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma China
- 24 Oct 2019 Planned End Date changed from 1 Mar 2020 to 1 May 2021.
- 24 Oct 2019 Planned primary completion date changed from 1 Sep 2019 to 1 Oct 2020.
- 31 Oct 2018 Status changed from not yet recruiting to recruiting.